COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety

Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and associated mortality than the general population. Owing to this increased risk, patients with cancer have been prioritized for COVID-19 vaccination globally, for both primary and booster vaccinations. However, given...

Descripción completa

Detalles Bibliográficos
Autores principales: Fendler, Annika, de Vries, Elisabeth G. E., GeurtsvanKessel, Corine H., Haanen, John B., Wörmann, Bernhard, Turajlic, Samra, von Lilienfeld-Toal, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916486/
https://www.ncbi.nlm.nih.gov/pubmed/35277694
http://dx.doi.org/10.1038/s41571-022-00610-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916486/
https://www.ncbi.nlm.nih.gov/pubmed/35277694
http://dx.doi.org/10.1038/s41571-022-00610-8

Ejemplares similares